4//SEC Filing
Mahadevia Ankit 4
Accession 0000950170-24-011496
CIK 0001701108other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 8:50 PM ET
Size
5.5 KB
Accession
0000950170-24-011496
Insider Transaction Report
Form 4
Mahadevia Ankit
Director
Transactions
- Sale
Common Stock
2024-02-02$1.37/sh−63,795$87,399→ 744,997 total
Footnotes (3)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted to the Reporting Person on February 1, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $1.36 to $1.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001720974
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 8:50 PM ET
- Size
- 5.5 KB